Market Overview

The Global Vascular Screening Market was valued at USD 1,839.2 million in 2023 and is expected to reach USD 2,887.5 million by 2031 while growing at a CAGR of 5.8% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global vascular screening market growth. Vascular screenings are crucial for evaluating the risk of health complications related to blood vessels and arteries. Through these screenings, our vascular technologists can identify warning signs of cardiovascular disease, which may lead to heart attacks or strokes, as well as abdominal aortic aneurysms. Early detection is vital for addressing these health concerns effectively.

The increasing occurrence of cardiovascular diseases, coupled with growing awareness and education, as well as an aging population, propels market growth. However, cost constraints and limited access to healthcare services act as barriers to market expansion.

Furthermore, the global vascular screening industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Product Type Analysis

The Global Vascular Screening Market is segmented among Portable, and Standalone, based on Product Type. In 2023, Portable accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By End User Analysis

The Global Vascular Screening Market is segmented among Hospitals, Diagnostic Centres/Clinics, and Other End Users, based on Type. In 2023, Hospitals accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Vascular Screening Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Collaborative Care Diagnostics LLC (Biomedix), CorVascular Diagnostics, LLC, D.E. Hokanson Inc., enverdis GmbH, Fukuda, Koven Technology Inc., OMRON HEALTHCARE Co. Ltd, Shenzhen Mindray Bio-Medical Electronics Co. Ltd, Unetixs Vascular Inc., and Viasonix

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Vascular Screening Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Vascular Screening Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Vascular Screening Market Segmentation, By Product Type

• Global Vascular Screening Market Share Analysis, By Product Type

• Global Vascular Screening Market Growth Analysis, By Product Type

• Global Vascular Screening Market Trends, By Product Type

o Portable

o Standalone

6. Global Vascular Screening Market Segmentation, By End User

• Global Vascular Screening Market Share Analysis, By End User

• Global Vascular Screening Market Growth Analysis, By End User

• Global Vascular Screening Market Trends, By End User

o Hospitals

o Diagnostic Centres/Clinics

o Other End Users

7. Global Vascular Screening Market Segmentation, By Region

• Global Vascular Screening Market Share Analysis, By Region

• Global Vascular Screening Market Growth Analysis, By Region

• Global Vascular Screening Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Collaborative Care Diagnostics LLC (Biomedix)*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• CorVascular Diagnostics, LLC

• D.E. Hokanson Inc.

• enverdis GmbH

• Fukuda

• Koven Technology Inc.

• OMRON HEALTHCARE Co. Ltd

• Shenzhen Mindray Bio-Medical Electronics Co. Ltd

• Unetixs Vascular Inc.

• Viasonix

*Similar analysis will be provided for each company listed above.